National Vaccine
Information Center

Your Health. Your Family. Your Choice.
Search Results

From the 12/24/2020 release of VAERS data (an older release, current is 1/7/2022):

This is VAERS ID 902770

Government Disclaimer on use of this data

Case Details

VAERS ID: 902770 (history)  
Form: Version 2.0  
Age: 50.0  
Sex: Female  
Location: Arkansas  
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2020-12-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Private       Purchased by: ?
Symptoms: Pruritus, Rash maculo-papular
SMQs:, Anaphylactic reaction (broad), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies: Lisinopril, Loracarbef, warfarin, Bydureon pen
Diagnostic Lab Data:
CDC Split Type:

Write-up: Patient started to develop maculopapular rash and itching starting ~15 minutes after the vaccine administration. The patient did not report shortness of breath or other respiratory symptoms. The patient was given IV diphenhydramine 50 mg, famotidine 20 mg IV, and methylprednisolone 125 mg IV. The patient''s symptoms resolved and was sent home with a Medrol dose pack and antihistamine.

New Search

Link To This Search Result:

Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166